News | May 12, 2015

International study suggests causal connection, but exact mechanism for cancer growth remains unknown

men, breast cancer, high estrogen levels, Cancer Research UK

May 12, 2015 — Men with naturally high levels of estrogen may have a greater risk of developing breast cancer, according to research by an international collaboration including Cancer Research UK. The study was published in the Journal of Clinical Oncology.

This is the first time a link between estrogen levels in the blood and male breast cancer has been identified, despite the hormone’s connection to breast, womb and ovarian cancers in women.

Men with the highest levels of estrogen were two and a half times more likely to develop breast cancer than men with the lowest levels of the hormone.

Male breast cancer is very rare, with one man in every 100,000 diagnosed with breast cancer each year in the U.K. Around 350 male cases are diagnosed each year in the U.K. compared with nearly 50,000 cases of breast cancer in women.

The research at the National Cancer Institute in the United States was part of an international collaboration between Cancer Research UK, the National Cancer Institute and others.

The aim was to study a large international pool of men with breast cancer. The research compared estrogen levels in 101 men who went on to develop breast cancer with 217 healthy men.

Mark Cross, 46, a police officer from Cambridgeshire, was diagnosed with breast cancer in 2009. He had a mastectomy and then follow-up treatment of chemotherapy and radiotherapy. His treatment ended in September 2010. He said: "The police sometimes get a bit of a reputation for being macho but I had great support from everyone within the Metropolitan police service. Not many people know that men get breast cancer too and it was a complete surprise to be diagnosed. My advice to all men is if you develop a lump on your chest — or anywhere else on your body — get it checked by your doctor as soon as possible. I hope my experience will raise awareness for other men."

Study author Prof. Tim Key, Cancer Research UK's hormone and nutrition expert at the University of Oxford, said: "We've shown for the first time that just like some forms of the cancer in women, estrogen has a big role to play in male breast cancer. So now the challenge is to find out exactly what this hormone is doing to trigger this rare form of the disease in men, and why some men have higher levels of estrogen in their blood. Our discovery is a crucial step forward in understanding the factors behind male breast cancer."

The symptoms, diagnosis and treatment of male breast cancer are very similar to breast cancer in women. The main risk of developing the disease in men is age, and almost eight in 10 cases are diagnosed in those aged 60 and older.

Julie Sharp, M.D., head of health information at Cancer Research UK, said: "Breast cancer in men isn't discussed very often, so a diagnosis can be a big shock for the small group of men who develop the disease.

"Some of the estrogen variation in men will simply be natural, but for others there may be a link to being overweight. Fat cells in the body are thought to drive up the body's level of this hormone in men and women, so this is another good reason to try and keep a healthy weight.

"This early research is crucial in understanding why these men get breast cancer - so that one day we can treat it more effectively."

For more information: www.cancerresearchuk.org


Related Content

News | FDA

Dec. 8, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, has submitted a 510(k) premarket ...

Time December 08, 2025
arrow
News | Breast Imaging

Dec. 01, 2025 — DeepHealth, a wholly owned subsidiary of RadNet, Inc., has launched the DeepHealth Breast Suite,2 an end ...

Time December 04, 2025
arrow
News | Women's Health

Dec. 1, 2025 — A study of data from seven outpatient facilities in the New York region found that 20-24% of all the ...

Time December 02, 2025
arrow
News | Artificial Intelligence

Nov. 6, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, recently announced that Volpara ...

Time November 07, 2025
arrow
Feature | Breast Imaging

Despite decades of progress in breast imaging, one challenge continues to test even the most skilled radiologists ...

Time October 24, 2025
arrow
News | Focused Ultrasound Therapy

Aug. 26, 2025 — In a quest for ever-more-effective treatments for pancreatic cancer, HonorHealth Research Institute is ...

Time August 29, 2025
arrow
News | Artificial Intelligence

March 10, 2025 — Lunit, a provider of AI-powered solutions for cancer diagnostics and therapeutics, has published a ...

Time March 10, 2025
arrow
News | Breast Imaging

July 29, 2024 — iCAD, Inc., a global leader in clinically proven AI-powered cancer detection solutions, announced a ...

Time July 29, 2024
arrow
News | Radiology Business

July 25, 2024 — Immunis, Inc., a clinical-stage biotech developing groundbreaking secretome therapeutics for age and ...

Time July 25, 2024
arrow
Videos | Breast Imaging

Don't miss ITN's latest "One on One" video interview with AAWR Past President and American College of Radiology (ACR) ...

Time July 24, 2024
arrow
Subscribe Now